Mecloretamina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Mecloretamina" in Italian language version.

refsWebsite

Global rank Italian rank

14nih.gov

4^th place

9^th place

4archive.org

6^th place

8^th place

4doi.org

2^nd place

7^th place

2oadoi.org

799^th place

22^nd place

1cancernetwork.com

low place

1web.archive.org

1^st place

archive.org

A. Gilman, The initial clinical trial of nitrogen mustard., in Am J Surg, vol. 105, Mag 1963, pp. 574-8, PMID 13947966.
Meyer AH, Overmiller WC, The use of nitrogen mustard in Hodgkin's disease and lymphosarcoma, in Ann. Intern. Med., vol. 30, n. 2, febbraio 1949, pp. 381–6, PMID 18109292.
Lowenbraun S, DeVita VT, Serpick AA, Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcoma, in Cancer, vol. 25, n. 5, Mag 1970, pp. 1018–25, PMID 4910254.
Vonderheid EC, Topical mechlorethamine chemotherapy. Considerations on its use in mycosis fungoides, in Int. J. Dermatol., vol. 23, n. 3, aprile 1984, pp. 180–6, PMID 6373639.

cancernetwork.com

Takimoto CH, Calvo E. "Principles of Oncologic Pharmacotherapy" Archiviato il 15 maggio 2009 in Internet Archive. in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) Cancer Management: A Multidisciplinary Approach Archiviato il 4 ottobre 2013 in Internet Archive.. 11 ed. 2008.

doi.org

dx.doi.org

J. Hirsch, An anniversary for cancer chemotherapy., in JAMA, vol. 296, n. 12, settembre 2006, pp. 1518-20, DOI:10.1001/jama.296.12.1518, PMID 17003400.
Al-Tonbary Y, Sarhan MM, El-Ashry RA, Salama E, Sedki M, Fouda A, Comparative study of two mechlorethamine, vincristine, procarbazine, and prednisone derived chemotherapeutic protocols for the management of pediatric Hodgkin lymphoma (HL): single-center 5-year experience, in Leuk. Lymphoma, vol. 51, n. 4, aprile 2010, pp. 656–63, DOI:10.3109/10428191003624249, PMID 20218813.
Michaelson-Richie ED, Ming X, Codreanu SG, Loeber RL, Liebler DC, Campbell C, Tretyakova NY, Mechlorethamine-induced DNA-protein cross-linking in human fibrosarcoma (HT1080) cells, in J. Proteome Res., vol. 10, n. 6, Giu 2011, pp. 2785–96, DOI:10.1021/pr200042u, PMC 3208907, PMID 21486066.
Brusamolino E, Gotti M, Fiaccadori V, The Risk of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia in Hodgkin Lymphoma has Substantially Decreased in the ABVD Era Abolishing Mechlorethamine and Procarbazine and Limiting Volumes and Doses of Radiotherapy, in Mediterr J Hematol Infect Dis, vol. 4, n. 1, 2012, pp. e2012022, DOI:10.4084/MJHID.2012.022, PMC 3375741, PMID 22708037.

nih.gov

ncbi.nlm.nih.gov

S. Rappeneau, A. Baeza-Squiban; C. Jeulin; F. Marano, Protection from cytotoxic effects induced by the nitrogen mustard mechlorethamine on human bronchial epithelial cells in vitro., in Toxicol Sci, vol. 54, n. 1, marzo 2000, pp. 212-21, PMID 10746948.
A. Gilman, The initial clinical trial of nitrogen mustard., in Am J Surg, vol. 105, Mag 1963, pp. 574-8, PMID 13947966.
WW. Faloon, LW. Gorham, Clinical experience with nitrogen mustard., in N Y State J Med, vol. 48, n. 6, marzo 1948, pp. 612-6, PMID 18904341.
J. Hirsch, An anniversary for cancer chemotherapy., in JAMA, vol. 296, n. 12, settembre 2006, pp. 1518-20, DOI:10.1001/jama.296.12.1518, PMID 17003400.
Al-Tonbary Y, Sarhan MM, El-Ashry RA, Salama E, Sedki M, Fouda A, Comparative study of two mechlorethamine, vincristine, procarbazine, and prednisone derived chemotherapeutic protocols for the management of pediatric Hodgkin lymphoma (HL): single-center 5-year experience, in Leuk. Lymphoma, vol. 51, n. 4, aprile 2010, pp. 656–63, DOI:10.3109/10428191003624249, PMID 20218813.
DeVita VT, Lewis BJ, Rozencweig M, Muggia FM, The chemotherapy of Hodgkin's disease: past experiences and future directions, in Cancer, vol. 42, 2 Suppl, Ago 1978, pp. 979–90, PMID 356960.
Michaelson-Richie ED, Ming X, Codreanu SG, Loeber RL, Liebler DC, Campbell C, Tretyakova NY, Mechlorethamine-induced DNA-protein cross-linking in human fibrosarcoma (HT1080) cells, in J. Proteome Res., vol. 10, n. 6, Giu 2011, pp. 2785–96, DOI:10.1021/pr200042u, PMC 3208907, PMID 21486066.
Meyer AH, Overmiller WC, The use of nitrogen mustard in Hodgkin's disease and lymphosarcoma, in Ann. Intern. Med., vol. 30, n. 2, febbraio 1949, pp. 381–6, PMID 18109292.
Lowenbraun S, DeVita VT, Serpick AA, Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcoma, in Cancer, vol. 25, n. 5, Mag 1970, pp. 1018–25, PMID 4910254.
Breneman DL, Nartker AL, Ballman EA, Pruemer JM, Blumsack RF, Davis M, Breneman JC, Topical mechlorethamine in the treatment of mycosis fungoides. Uniformity of application and potential for environmental contamination, in J. Am. Acad. Dermatol., vol. 25, 6 Pt 1, dicembre 1991, pp. 1059–64, PMID 1844356.
Vonderheid EC, Topical mechlorethamine chemotherapy. Considerations on its use in mycosis fungoides, in Int. J. Dermatol., vol. 23, n. 3, aprile 1984, pp. 180–6, PMID 6373639.
Price NM, Deneau DG, Hoppe RT, The treatment of mycosis fungoides with ointment-based mechlorethamine, in Arch Dermatol, vol. 118, n. 4, aprile 1982, pp. 234–7, PMID 7065680.
Price NM, Hoppe RT, Deneau DG, Ointment-based mechlorethamine treatment for mycosis fungoides, in Cancer, vol. 52, n. 12, Dic 1983, pp. 2214–9, PMID 6640491.
Brusamolino E, Gotti M, Fiaccadori V, The Risk of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia in Hodgkin Lymphoma has Substantially Decreased in the ABVD Era Abolishing Mechlorethamine and Procarbazine and Limiting Volumes and Doses of Radiotherapy, in Mediterr J Hematol Infect Dis, vol. 4, n. 1, 2012, pp. e2012022, DOI:10.4084/MJHID.2012.022, PMC 3375741, PMID 22708037.

oadoi.org

J. Hirsch, An anniversary for cancer chemotherapy., in JAMA, vol. 296, n. 12, settembre 2006, pp. 1518-20, DOI:10.1001/jama.296.12.1518, PMID 17003400.
Al-Tonbary Y, Sarhan MM, El-Ashry RA, Salama E, Sedki M, Fouda A, Comparative study of two mechlorethamine, vincristine, procarbazine, and prednisone derived chemotherapeutic protocols for the management of pediatric Hodgkin lymphoma (HL): single-center 5-year experience, in Leuk. Lymphoma, vol. 51, n. 4, aprile 2010, pp. 656–63, DOI:10.3109/10428191003624249, PMID 20218813.

web.archive.org

Takimoto CH, Calvo E. "Principles of Oncologic Pharmacotherapy" Archiviato il 15 maggio 2009 in Internet Archive. in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) Cancer Management: A Multidisciplinary Approach Archiviato il 4 ottobre 2013 in Internet Archive.. 11 ed. 2008.